Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo.
Zhou Z, Fang Q, Ma D, Zhe N, Ren M, Cheng B, Li P, Liu P, Lin X, Tang S, Hu X, Liao Y, Zhang Y, Lu T, Wang J.
Zhou Z, et al. Among authors: lu t.
Oncotarget. 2017 Jul 28;8(45):78480-78495. doi: 10.18632/oncotarget.19652. eCollection 2017 Oct 3.
Oncotarget. 2017.
PMID: 29108243
Free PMC article.